Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
Document Actions
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). A metabolic syndrome phenotype, detected using the NCEP-ATP III criteria, was present in 76% of 1 436 patients with atherogenic dyslipidaemia (defined as low HDL-cholesterol with elevated triglycerides) participating in the Genetic Epidemiology of Metabolic Syndrome Project. The syndrome was more frequent in those aged 36-55 years and ≥55 years (82% and 88%, respectively) than in those aged ≤35 years (41%).
Authors: Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesaniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM.
PMID/ref: Am J Cardiol 2005;95:194-8.
